JP2002508326A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002508326A5 JP2002508326A5 JP2000538696A JP2000538696A JP2002508326A5 JP 2002508326 A5 JP2002508326 A5 JP 2002508326A5 JP 2000538696 A JP2000538696 A JP 2000538696A JP 2000538696 A JP2000538696 A JP 2000538696A JP 2002508326 A5 JP2002508326 A5 JP 2002508326A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- aminocarbonyl
- amino
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- HBWCJMBLUCNJIS-UHFFFAOYSA-N Cc1nc(NCCC2)c2cc1 Chemical compound Cc1nc(NCCC2)c2cc1 HBWCJMBLUCNJIS-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6990997P | 1997-12-17 | 1997-12-17 | |
| GBGB9807384.4A GB9807384D0 (en) | 1998-04-06 | 1998-04-06 | Vitronectin receptor antagonists |
| US8325098P | 1998-04-27 | 1998-04-27 | |
| US9263098P | 1998-07-13 | 1998-07-13 | |
| GB9807384.4 | 1998-07-21 | ||
| GB60/083,250 | 1998-07-21 | ||
| GBGB9815803.3A GB9815803D0 (en) | 1998-07-21 | 1998-07-21 | Vitronectin receptor antagonists |
| GB60/069,909 | 1998-07-21 | ||
| GB60/092,630 | 1998-07-21 | ||
| GB9815803.3 | 1998-07-21 | ||
| PCT/US1998/026485 WO1999030713A1 (en) | 1997-12-17 | 1998-12-14 | Integrin receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002508326A JP2002508326A (ja) | 2002-03-19 |
| JP2002508326A5 true JP2002508326A5 (cg-RX-API-DMAC7.html) | 2006-02-02 |
Family
ID=27517454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000538696A Withdrawn JP2002508326A (ja) | 1997-12-17 | 1998-12-14 | インテグリン受容体拮抗薬 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1044001B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002508326A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE299023T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU738452B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2315232A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69830806T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2243015T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999030713A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006169A1 (en) * | 1998-07-29 | 2000-02-10 | Merck & Co., Inc. | Integrin receptor antagonists |
| AU748621B2 (en) * | 1998-08-13 | 2002-06-06 | Merck & Co., Inc. | Integrin receptor antagonists |
| WO2000047207A1 (en) | 1999-02-09 | 2000-08-17 | Bristol-Myers Squibb Company | LACTAM INHIBITORS OF FXa AND METHOD |
| BR0009739A (pt) | 1999-04-13 | 2002-04-09 | Basf Ag | Composto, medicamento, preparação farmacêutica, e, usos de um elemento estrutural, de um composto e de uma preparação farmacêutica |
| DE60035779T2 (de) | 1999-06-02 | 2008-04-30 | Merck & Co., Inc. | Alpha v integrin-rezeptor antagonisten |
| US6514964B1 (en) | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
| EP1229910A4 (en) | 1999-10-04 | 2003-10-01 | Merck & Co Inc | integrin |
| US6849639B2 (en) | 1999-12-14 | 2005-02-01 | Amgen Inc. | Integrin inhibitors and their methods of use |
| WO2001053297A1 (en) | 2000-01-20 | 2001-07-26 | Merck & Co., Inc. | Alpha v integrin receptor antagonists |
| JP2004511434A (ja) | 2000-06-15 | 2004-04-15 | ファルマシア・コーポレーション | インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸 |
| US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
| WO2002022615A1 (en) | 2000-09-14 | 2002-03-21 | Merck & Co., Inc. | Alpha v integrin receptor antagonists |
| WO2002060438A1 (en) | 2001-01-29 | 2002-08-08 | 3-Dimensional Pharmaceuticals, Inc. | Substituted indoles and their use as integrin antagonists |
| CN1247258C (zh) | 2001-04-24 | 2006-03-29 | 默克专利有限公司 | 使用抗血管生成剂和TNFα的联合疗法 |
| US6872730B2 (en) | 2001-04-27 | 2005-03-29 | 3-Dimensional Pharmaceuticals, Inc. | Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| EP1539739B1 (en) * | 2002-08-16 | 2010-11-24 | Janssen Pharmaceutica NV | Piperidinyl compounds that selectively bind integrins |
| BR0316876A (pt) | 2002-12-20 | 2005-10-25 | Pharmacia Corp | Compostos de tiazol e composição farmacêutica compreendendo o mesmo |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| KR20080089489A (ko) | 2006-01-18 | 2008-10-06 | 메르크 파텐트 게엠베하 | 인테그린 리간드를 사용하는 암치료용 특이적 요법 |
| EA017864B1 (ru) | 2007-01-18 | 2013-03-29 | Мерк Патент Гмбх | Специфическая терапия и лекарственное средство на основе интегриновых лигандов для лечения рака |
| AU2010252280A1 (en) | 2009-05-25 | 2012-01-19 | Merck Patent Gmbh | Continuous administration of cilengitide in cancer treatments |
| DK3929196T3 (da) | 2013-09-24 | 2023-09-25 | Fujifilm Corp | Farmaceutisk sammensætning af en nitrogenholdig forbindelse eller salt deraf, eller metalkompleks deraf |
| ES2864079T3 (es) | 2014-05-30 | 2021-10-13 | Pfizer | Derivados de carbonitrilo como moduladores selectivos del receptor de andrógenos |
| US11046685B2 (en) | 2017-02-28 | 2021-06-29 | Morphic Therapeutic, Inc. | Inhibitors of (α-v)(β-6) integrin |
| EP4159727B1 (en) | 2017-02-28 | 2026-04-08 | Morphic Therapeutic, Inc. | Inhibitors of (alpha-v)(beta-6) integrin |
| PT3844162T (pt) | 2018-08-29 | 2025-03-28 | Morphic Therapeutic Inc | Inibidores da integrina alfa v beta6 |
| WO2020047208A1 (en) | 2018-08-29 | 2020-03-05 | Morphic Therapeutic, Inc. | Inhibitors of (alpha-v)(beta-6) integrin |
| AU2019327475B2 (en) | 2018-08-29 | 2025-06-05 | Morphic Therapeutic, Inc. | INHIBITING αV β6 INTEGRIN |
| DK3873884T3 (da) | 2018-10-30 | 2025-02-17 | Gilead Sciences Inc | 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme |
| WO2020092401A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN |
| ES2987796T3 (es) | 2018-10-30 | 2024-11-18 | Gilead Sciences Inc | Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias |
| WO2020092394A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
| AU2020329207B2 (en) | 2019-08-14 | 2024-02-29 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4929618A (en) * | 1988-03-25 | 1990-05-29 | Ube Industries, Ltd. | Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same |
-
1998
- 1998-12-14 DE DE69830806T patent/DE69830806T2/de not_active Expired - Fee Related
- 1998-12-14 JP JP2000538696A patent/JP2002508326A/ja not_active Withdrawn
- 1998-12-14 EP EP98963893A patent/EP1044001B1/en not_active Expired - Lifetime
- 1998-12-14 CA CA002315232A patent/CA2315232A1/en not_active Abandoned
- 1998-12-14 WO PCT/US1998/026485 patent/WO1999030713A1/en not_active Ceased
- 1998-12-14 AT AT98963893T patent/ATE299023T1/de not_active IP Right Cessation
- 1998-12-14 ES ES98963893T patent/ES2243015T3/es not_active Expired - Lifetime
- 1998-12-14 AU AU19128/99A patent/AU738452B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2609767T3 (es) | Combinaciones de un inhibidor de PI3K y un inhibidor de MEK | |
| RU2483061C2 (ru) | Тетрагидропиранохроменовые ингибиторы гамма-секретазы | |
| BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
| JP2006522813A5 (cg-RX-API-DMAC7.html) | ||
| CA2373653C (en) | New use of compounds as antibacterial agents | |
| EP3189854B1 (en) | Vaccine composition for transdermal or transmucosal administration | |
| JP2003500442A5 (cg-RX-API-DMAC7.html) | ||
| JP2018505169A5 (cg-RX-API-DMAC7.html) | ||
| KR20220003552A (ko) | 레날리도미드 및 다른 면역조정제의 연속적 전달 | |
| JP2004517843A5 (cg-RX-API-DMAC7.html) | ||
| JP2006508091A5 (cg-RX-API-DMAC7.html) | ||
| RU96120189A (ru) | Новые фармацевтические препараты и способы их получения | |
| JP2004533428A5 (cg-RX-API-DMAC7.html) | ||
| CA2440037A1 (en) | Benzimidazole derivatives for modulating the rage receptor | |
| JP2000512993A (ja) | H▲上+▼,k▲上+▼−atpアーゼ阻害剤の投与計画 | |
| WO2004052847A3 (en) | Tricyclic steroid hormone nuclear receptor modulators | |
| EA200000700A3 (ru) | НОВЫЕ β- КАРБОЛИНОВЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИХ | |
| RU99101081A (ru) | Режим введения ингибиторов н+, к+-атфазы | |
| JP2002542298A5 (cg-RX-API-DMAC7.html) | ||
| EP1125936A3 (en) | Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases | |
| CA2415476C (en) | Matrix controlled transdermal system for stabile derivatives of ace inhibitors | |
| JPH1036365A5 (cg-RX-API-DMAC7.html) | ||
| JP2006509759A (ja) | パレコキシブ(parecoxib)、バルデコキシブ(valdecoxib)およびベンゾピラン誘導体のような水溶性の選択的シクロオキシゲナーゼ−2阻害剤の経皮投与 | |
| WO2005065664A8 (en) | Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent | |
| MXPA05004990A (es) | Parche de inhibidor selectivo de ciclooxigenasa-2. |